1-[(2S,3S,4R,5R,6R)-6-carboxylato-3,4,5-trihydroxyoxan-2-yl]-3-[(2S)-1-methyl-5-oxopyrrolidin-2-yl]-1λ5-pyridin-1-ylium

• ChemBase编号: 164989
• 分子式: C16H20N2O7
• 平均质量: 352.3392
• 单一同位素质量: 352.12705099
• SMILES: C1C[C@H](N(C1=O)C)c1c[n+](ccc1)[C@H]1O[C@@H]([C@@H]([C@H]([C@H]1O)O)O)C(=O)[O-]
• Canonical SMILES: [O-]C(=O)[C@H]1O[C@H]([n+]2cccc(c2)[C@@H]2CCC(=O)N2C)[C@@H]([C@@H]([C@H]1O)O)O
• InChI: InChI=1S/C16H20N2O7/c1-17-9(4-5-10(17)19)8-3-2-6-18(7-8)15-13(22)11(20)12(21)14(25-15)16(23)24/h2-3,6-7,9,11-15,20-22H,4-5H2,1H3/t9-,11+,12+,13-,14+,15-/m0/s1
• InChIKey: XWZCZWKUGIQPJD-GLEXUSGWSA-N

名称和登记号

名称

• IUPAC标准名: 1-[(2S,3S,4R,5R,6R)-6-carboxylato-3,4,5-trihydroxyoxan-2-yl]-3-[(2S)-1-methyl-5-oxopyrrolidin-2-yl]-1λ^5-pyridin-1-ylium
• IUPAC传统名: 1-[(2S,3S,4R,5R,6R)-6-carboxylato-3,4,5-trihydroxyoxan-2-yl]-3-[(2S)-1-methyl-5-oxopyrrolidin-2-yl]-1λ^5-pyridin-1-ylium
• 别名: 1-β-D-Glucopyranuronosyl-3-[(2S)-1-methyl-5-oxo-2-pyrrolidinyl]pyridinium Inner Salt; Cotinine-N-glucuronide; Cotinine N-β-D-Glucuronide

登记号

• CAS号: 139427-57-9
• PubChem SID: 162259122
• PubChem CID: 71314990

理论计算性质

• Acid pKa: 2.8463566
• 质子受体: 7
• 质子供体: 3
• LogD (pH = 5.5): -6.05522
• LogD (pH = 7.4): -6.055902
• Log P: -5.8264213
• 摩尔折射率: 93.8025 cm^3
• 极化性: 32.83517 Å^3
• 极化表面积: 134.24 Å^2
• 可自由旋转的化学键: 3
• 里宾斯基五规则: true

分子性质

理化性质

• 溶解度: Water
• 外观: White to Off-White Solid
• 熔点: >150°C (dec.)

安全信息

• 保存条件: -20°C Freezer, Under Inert Atmosphere

详细说明

Toronto Research Chemicals - C725175

A major metabolite of Nicotine in humans. Carcinogen.

参考文献

• Benowitz, N., et al.: Clin. Pharmacol. Ther., 56, 483 (1994)
• Nakajima, M., et al.: Drug Metab. Dispos., 24, 1212 (1994)
• Messina, E., et al.: J. Pharmacol. Exp. Ther., 282, 1608 (1994)
• Oscarson, M., et al.: Hum. Mutat., 20, 275 (1994)